Global Clinical Trials Supply & Logistics Market Global Clinical Trials Supply & Logistics Market Dublin, Sept. 30, 2022 (GLOBE NEWSWIRE) -- The “Clinical Trials Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), by Phase, by En…
CHARLOTTE, N.C., Sept. 30, 2022 /PRNewswire/ -- Husqvarna Group, one of the world's leading manufacturers of innovative outdoor power equipment products, demonstrated the future of landscaping at the first annual
GEORGETOWN, Texas--(BUSINESS WIRE)--Sep 27, 2022--
Connect in Pharma had its debut launch on 14 & 15 September in Geneva, showcasing the newest trends in drug manufacturing and delivery.
Group’s quarterly performance supported by higher demand for ICT products from local customersIPOH, Malaysia, Sept 27, 2022 - (ACN Newswire) - SNS Network Technology Berhad (SNS), an ICT system and solutions provider, today announced that the Group regist
Visiongain has launched a new report on the Global Pharmaceutical Contract Manufacturing Market Forecast 2022-2032: - Market Segment by Services {Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services), Drug Development Services, B…
Visiongain has launched a new report on Deep Frozen Packaging Logistics Market Report 2022-2032: Market Segment by Type (Dry Shippers, Dry Ice Shipper),
The Cellular and Gene Therapy CDMO Market research report provide in depth information on market trends market capacity industry size growth factors share innovations competitive environment business problems and more This report s historical data confirms demand growth on a ...
SOMERSET, N.J. - Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple... | September 7, 2022
Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, announced today that its CEO, Dr. James Helliwell will present at the H.C. Wainwright 24th Annual Global Investment Conferen..…
Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) a drug discovery and development company focused on creating novel, optimized, next-generation psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical n.…
North America Nasal Spray business report takes into account almost all vital parameters for company profiling, including market share, recent
Global biopharmaceutical contract manufacturing market was estimated to be worth roughly US$ 8.4 billion in 2021 and is expected to grow at a CAGR of 10.5% to reach US$ 18.7 billion by 2029.Reduced overall time to market investment in new drugs, access to expensive technologies, and greater flexi...
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The “Mesenchymal Stem Cells - Advances and Applications, 2022” report has been added to ResearchAndMarkets.com’s offering. Today, nearly one-hundred different market competitors are developing various types of MSC-related products and services, therapies, a…
DBMR published a research report on Global Pharmaceutical Gelatin Market Industry Analysis, Size, Share, Growth, Trends and Forecast to 2029.
→ In the Big Pharma world, companies like J&J and Merck have experienced a pronounced sea change in leadership over a two-year period, and you can begin to say the same at Novartis, which dismissed head of development John Tsai and head of oncology Susanne Schaffert as part of CEO
The
One of the major factors driving market expansion is a huge increase in migraine cases. Also, the market is benefiting from improved reimbursement policies...
A Chinese CDMO has managed to put together a sizable Series B. Porton Advanced Solutions has completed the financing round garnering over $80 million. The company will use the funds to continue its business expansion into different markets, with investment in manufacturing infrastructure and global…
Brazil’s National Health Surveillance Agency (Anvisa) approved the registration exemption for the Health Ministry to import and use the Bavarian Nordic vaccine and the drug Tecovirimat.